The findings will allow for more targeted treatment approaches.
newsok
OMRF scientist receives $300,000 from Lupus Research Alliance
The Lupus Research Alliance is the world’s leading private funder of lupus research.
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF scientists discover potential therapeutic target for lymphedema
Lymphedema is a disease characterized by dramatic and painful swelling in the limbs that often leads to infections.
Oklahoma teen lives with unique skeletal disorder
Sydney Rutz is one in five billion.
OMRF accepting 2020 Fleming Scholar applications
The application deadline is Feb. 1.
